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Testing the many hypotheses from genomics and systems biology
experiments demands accurate and cost-effective gene and gen-
ome synthesis. Here we describe a microchip-based technology
for multiplex gene synthesis. Pools of thousands of ‘construction’
oligonucleotides and tagged complementary ‘selection’ oligonu-
cleotides are synthesized on photo-programmable microfluidic
chips1, released, amplified and selected by hybridization
to reduce synthesis errors ninefold. A one-step polymerase
assembly multiplexing reaction assembles these into multiple
genes. This technology enabled us to synthesize all 21 genes that
encode the proteins of the Escherichia coli 30S ribosomal subunit,
and to optimize their translation efficiency in vitro through
alteration of codon bias. This is a significant step towards the
synthesis of ribosomes in vitro and should have utility for
synthetic biology in general.
The advance of large-scale biochemical analyses such as sequen-
cing, microarrays and proteomics has generated vast amounts of
data, which computational biologists have leveraged into a large
number of hypotheses. To test these hypotheses we must first
overcome the bottleneck in constructing new genetic elements,
genetic pathways and engineered cells. To optimize complex bio-
logical processes using darwinian selection, we need to direct the
finite diversity available in combinatorial oligonucleotide synthesis
(about 25 randomized base pairs (bp) or equivalents) thoughtfully
through large stretches (at the megabase level) of DNA sequence.
These represent great challenges and potential payoffs for the
emerging field of synthetic biology.
In principle, we can create a useful variety of molecules, cellular
and cell-free systems given a sufficient supply of custom genes and
genomes. However, current methods for generating even basic
oligonucleotides are expensive (US$0.11 per nucleotide) and have
very high levels of errors (deletions at a rate of 1 in 100 bases and
mismatches and insertions at about 1 in 400 bases). As a result, gene
or genome synthesis from oligonucleotides is both expensive and
prone to error. Correcting errors by clone sequencing and mutagen-
esis methods further increases the amount of labour and total cost
(to at least US$2 per base pair). In principle, the cost of oligo-
nucleotide synthesis can be reduced by performing massively
parallel custom syntheses on microchips1,2. This can now be
achieved using a variety of methods, including ink-jet printing
with standard reagents (Agilent), photolabile 5
0
protecting
groups (Nimblegen/Affymetrix), photo-generated acid deprotec-
tion (Atactic/Xeotron) and electrolytic acid/base arrays (Oxamer/
Combimatrix). However, current microchips have very low surface
areas and hence only small amounts of oligonucleotides can be
produced. When released into solution, the oligonucleotides are
present at pictomolar or lower concentrations per sequence, con-
centrations that are insufficiently high to drive bimolecular priming
reactions efficiently.
A potential solution to this scale problem would be to amplify the
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oligonucleotides obtained from the microchips from roughly as
little as 105 (or 109 for low density arrays) up to 109 (or 1012)
molecules of each sequence, thereby permitting subsequent selec-
tion and assembly steps. An overview of the integrated process is
presented in Fig. 1.
For this amplification method (shown in Fig. 2a), oligonucleo-
tides flanked by short, generic adaptor sequences are synthesized on
a programmable microchip. This generates a pool of 102–105
different oligonucleotides, which can be released from the micro-
chips by chemical or enzymatic treatment. Released oligonucleo-
tides are amplified by polymerase chain reaction (PCR) using
primers that contain type-IIS restriction enzyme recognition sites.
Digestion of the PCR products with the corresponding restriction
enzyme(s) yields sufficient amounts of unadulterated oligonucleo-
tide sequences to be used for gene or genome assembly.
We first demonstrated the feasibility of this approach with
Atactic/Xeotron 4K (that is, 3,968 synthesis chambers) photo-
programmable microfluidic microarrays1. To monitor oligonucleo-
tide synthesis and cleavage from the microchip, the 5 0 ends of the
oligonucleotides were coupled with fluorescein. The microchip was
scanned with a microarray scanner before and after cleavage, and
the images are shown in Fig. 2b. The cleaved portions of
the oligonucleotides were hybridized onto a ‘quality-assessment
(QA)-chip’ synthesized with complementary oligonucleotide
sequences (Fig. 2c). These results demonstrated that individual
oligonucleotides were synthesized and nearly completely released
from the microchip in quantities that can be measured by a QA-chip
hybridization process. The typical yield of oligonucleotide released
from each chamber of the 4K microchip is about 5 fmoles, as
determined by quantitative PCR1. Using primers that anneal
specifically to the generic adaptors flanking the oligonucleotide
sequences, PCR reactions were carried out to amplify the oligo-
nucleotides more than a million-fold.
Mutations incurred during oligonucleotide synthesis are a major
source of errors in assembled DNA molecules, and are costly
and difficult to eradicate4,5. We developed a simple, stringent
hybridization-based method to remove oligonucleotides with
such mutations. To select against mutations in gene construction
oligonucleotides, these oligonucleotides were hybridized sequen-
tially to two pools of bead-immobilized short complementary
selection oligonucleotides that together span the entire length of
the construction oligonucleotides (Fig. 3a). All selection oligo-
nucleotides were designed to have nearly identical melting tem-
peratures by varying their lengths. Under appropriate hybridization
conditions, imperfect pairs between selection and construction
oligonucleotides due to base-mismatch or deletion have lower
melting temperatures and are unstable. After the cycles of hybrid-
ization, wash and elution, oligonucleotides with sequences that
perfectly match the selection oligonucleotides are preferentially
retained and enriched. Digestion of the PCR products with type-
IIS restriction enzymes removed the generic primer sequences
from both ends of the oligonucleotides (Fig. 3b, lanes 1–2). In
these experiments the amplification tags are removed just before
selection. However, if the digestion were deferred, the oligonucleo-
tides could be re-amplified by PCR and subjected to further rounds
of hybridization selection. Because the probability of complemen-
tary mutations occurring at matching positions on construction
and selection oligonucleotides is miniscule, in principle most
oligonucleotides with mutations can be eliminated by this selection
procedure.
Like construction oligonucleotides, selection oligonucleotides
were also synthesized and released from programmable micro-
arrays. Selection oligonucleotides with arms were amplified by
PCR, and the strands complementary to the gene construction
oligonucleotide were labelled with biotin at the 5
0
end and selec-
tively immobilized on streptavidin beads. The unlabelled strands
were denatured and removed. As demonstrated in Fig. 3b (lane 3),
immobilized selection oligonucleotides selectively retained the
correct 50-bp construction oligonucleotides.
Such oligonucleotides are suitable for gene assembly. To facilitate
automation, we developed a single-step polymerase assembly multi-
plexing (PAM) reaction for multiple gene syntheses from a single
pool of oligonucleotides. Single-fragment assembly methods
Figure 1 A flow chart for the design, synthesis and analysis of multiple genes in pools.
Estimates of the current process timing (not always the minimum possible times) and
sources of additional details are listed.
Figure 2 Preparation of free oligonucleotides from a custom microarray. a, Diagram of
synthesis and cleavage of a PCR-amplifiable oligonucleotide from a microchip surface.
The portion of the oligonucleotide used for gene construction is in black; PCR primer-
adaptors are shown in grey. b, Synthesis and cleavage of oligonucleotides from a
Xeotron/Atactic 4K photo-programmable microfluidic microchip. Left: fluorescent
scanning micrograph of an oligonucleotide array before cleavage. Insert: details of
microfluidic chambers and connecting channels. Right: array after cleavage.
c, Hybridization of released fluorescein (FAM)-labelled oligonucleotides to a QA-chip.
Left: before hybridization; middle: after hybridization; right: after stripping of hybridized
oligonucleotides.
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have traditionally used two or three steps (ligation, assembly and
PCR)4–6. For PAM, gene-flanking primer pairs were added to the
pool of gene-construction oligonucleotides (with the primer pairs
at a higher concentration than the oligonucleotides), together with
thermostable polymerase and dNTPs. Extension of overlapping
oligonucleotides and subsequent amplification of multiple full-
length genes were accomplished in a closed-tube, one-step reaction
using a thermal cycler. Different generic adaptor sequences can be
incorporated into the ends of each gene or gene set, and a set of
complementary adaptor-primer pairs can be pre-synthesized to
avoid the cost of synthesizing gene-specific PAM primer pairs and
to facilitate automation (for example, 96 or 384 generic adaptors to
match standard multi-well plates).
To determine the efficiency of the hybridization-selection
method to eliminate mismatch mutations7, we constructed genes
using the same pool of microchip-synthesized oligonucleotides
purified in three different ways: unpurified, polyacrylamide gel
electrophoresis (PAGE)-purified or hybridization-purified. These
genes were cloned and random clones from each category were
sequenced in both directions to determine error types and rates for
each category. As shown in Table 1, genes synthesized with unpuri-
fied oligonucleotides have the highest error rates (1 in 160 bp); the
method of gene assembly (using ligation or PAM) made little
difference. PAGE purification of oligonucleotides reduced the
error rate to 1 in 450 bp, mainly through removal of deletion
mutations. This rate is comparable to figures reported by other
groups using PAGE purification4,5. With hybridization selection, the
error rate was further reduced to approximately 1 in 1,394 bp.
As an example of the usefulness of this technology for large-scale
synthetic biology projects8, we used a microchip to redesign and
synthesize codon-altered versions of the 21 protein-encoding genes
that constitute the E. coli small ribosomal subunit. We had pre-
viously noticed while using the natural versions of these 21 proteins9
that translational efficiencies were very low in vitro, even though
in vivo the proteins have high expression levels. Redesigning codon
usage is a way to increase protein translation efficiencies, although it
is more challenging to accomplish when starting with nearly ideal
codons. Because many other proteins are expressed well in this
in vitro system, we hypothesized that some of the problem was due
to secondary structure (possibly exacerbated by the fact that the rate
of T7 polymerase-mediated transcription is eightfold higher than
translation10,11). We attempted to replace codons with sequences
likely to have less secondary structure (for example, by lowering
G þ C content). Our computer-aided design software (CAD-PAM)
designed overlapping 50-bp oligonucleotide sequences (embedded
in 70-mers) for the 21 ribosomal genes and synthesized them all
on a 4K Xeochip. These oligonucleotides were processed and
hybridization-selected with selection oligonucleotides, and were
then used to construct the 21 ribosomal genes in multiple PAM
reactions (Fig. 4a). Error-free clones were tested in E. coli using
coupled in vitro transcription–translation reactions. The translation
profiles of the synthetic genes are shown in Fig. 4b. A number of
codon-altered genes had higher translation levels in the E. coli
extract compared with their respective wild-type genes. We next
combined these 21 genes using sequential PAM reactions to give
a pool of ,14.6 kb assemblies (Fig. 4c) by introducing unique
,30-mer overlapping linkers between gene units and performing
sequential PAM reactions. Correct assembly was confirmed
by sequencing on average four individual clones from every over-
Figure 3 Hybridization selection of microchip-synthesized oligonucleotides. a, Diagram of
the hybridization selection strategy. 90-mer oligonucleotides (upper strands black, lower
strands grey) are cut with type-IIS restriction enzymes to release hybrids of 50-mers and
complementary 44-mers, some of which have incorrect sequences (indicated by a bulge
in the upper strand of the second 90-mer oligonucleotide). Only the correct upper 50-mer
strand hybridizes well with left (L) then right (R) selection oligonucleotides (immobilized on
beads in grey). b, A denaturing PAGE gel separating PCR-amplified oligonucleotides
(90-mer, lane 1), BsaI/BseRI-digested oligonucleotides (50- and 44-mer, lane 2) and
hybridization-selected oligonucleotides (50-mer, lane 3). Ten-base-pair markers are
shown in lanes marked M.
Figure 4 Synthetic gene constructs and their translation products. a, Twenty-one
engineered ribosomal protein genes constructed using PAM reactions (upper gel) and
their in vitro transcribed RNAs (lower set of bands in the lower gel). b, Ribosomal proteins
translated from their synthetic genes. Western blot comparison of translation efficiency
between wild-type (WT) and engineered (M) versions of three ribosomal protein genes.
c, A 14.6-kb operon of 21 ribosomal genes assembled using sequential PAM reactions.
Left lane, DNA molecular weight marker IV (Roche).
Table 1 Comparison of sequence errors generated by various methods
Method Total bp Transition Transversion Deletion Addition bp per error
...................................................................................................................................................................................................................................................................................................................................................................
Hybridization selection (PAM) 23,641 7 3 5 2 1,394
PAGE selection (PAM) 24,546 28 12 11 3 455
No selection (PAM) 9,243 25 13 19 1 159
No selection (ligation) 6,093 6 6 22 4 160
...................................................................................................................................................................................................................................................................................................................................................................
We performed x2 tests for hybridrization selection versus PAGE selection (P ¼ 2 £ 1025), and hybridization selection versus no selection (P ¼ 2 £ 10221). Only the constructs in the row labelled ‘PAGE
selection’ involved gel purification.
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lapping DNA segment generated by high-fidelity PCR reactions that
together covered the whole construct. By starting with correct input
gene sequences, and through repeated high-fidelity, polymerase-
based extension reactions, the assembly process resulted in a lower
error rate (about 1 in 7,300 bp) than any of the methods shown in
Table 1 (all of which started with oligonucleotides containing
synthetic errors). This clearly demonstrated that a major source of
error for gene assembly comes from oligonucleotide chemical
synthesis rather than polymerase proofreading activity. Although
the increasing length of the PCR products might be expected to
reduce yield in the later assemblies, the number of reaction
components decreases and so the efficiency remains high. Even-
tually when PAM length does become limiting, homologous recom-
bination might allow assembly in the megabase range.
In this demonstration, a small fraction of a microchip’s synthetic
capacity was used. Massively parallel microchip-based oligonucleo-
tide synthesis might increase yields in oligonucleotide synthesis
from 9 bp per US$ to 20 kb per US$, depending on the type of
microchip used and the number of oligonucleotides on a microchip.
To achieve few or no errors in megabase-scale assemblies, the
progress here on mismatch errors must be extended. In addition
to the physical methods described here, we and others are using
protein-based methods (for example, using MutS12 or MutHLS
mismatch correction proteins) already shown to be capable of
exceeding by tenfold the fidelity of DNA polymerases (the latter
being 6 £ 1026 errors per base per cycle)13. This could significantly
reduce the money spent on sequencing and potentially eliminate the
need for error correction using directed-mutagenesis methods.
Ultra-low-cost DNA sequencing14 could also have a large impact
if properly integrated. The next stage in testing the limits to
simultaneous synthesis and assembly will employ 95,000–382,000
oligonucleotides per $700 microchip from Nimblegen (yielding
2–18 Mbp). The first such assembly has been successful (see
http://arep.med.harvard.edu/SBP/). Overcoming the challenge of
repeated sequences in desired synthetic constructs may require
approaches like hierarchical assembly, assembly focused on only
the unique ends, and/or multiplex size selections of assembly
products. Using geometrical constraints to force a certain order of
assembly illustrates another potential strength of microfluidic
syntheses. Improvement of error rates enables a variety of appli-
cations without cloning or sequencing.
Although oligonucleotide assembly is an established pro-
cedure6,15,16, our procedures for elution from DNA microchips,
oligonucleotide amplification, mismatch error correction, multi-
plexing and microfluidic integration are new. Accurate, low-cost
multiplex gene syntheses will be a powerful tool for synthetic
biology8 and complex nanostructures in general17. For example,
this technology is currently enabling us to improve and test
components needed for the synthesis of ribosomes in vitro. The
rapid prototyping of individual genes on short linear templates has
greatly aided the debugging of this complex system. Our ability to
remap a whole set of genes from the Mycoplasma18 codons to those
of E. coli (for example, by eliminating the UGA ‘stop’ codon and
changing G þ C content from 25% to 51%) will help us to calibrate
proteomics experiments, test de novo protein designs and identify
new biochemical activities, including those that are missing




Gene and oligonucleotide sequences were designed using the Java program CAD-PAM, to
be described in detail elsewhere (J.T., H.G. and G.C., manuscript in preparation). Basically,
CAD-PAM uses constraints on the amino acid sequences, codon usage, messenger RNA
secondary structure and restriction enzymes used to release the construction
oligonucleotides in order to create nearly optimal, overlapping sets of n-mer (typically
50-mer) construction oligomers and shorter selection oligomers (typically 26-mer). The
melting temperatures (Tm) of overlapping regions between adjacent gene construction
oligonucleotides or between construction and selection oligonucleotides were equalized.
The selection oligonucleotides were padded with extra adenine residues to keep oligomer
length constant (70-mers) for optional size selection (not used for typical PAM). Tm values
were calculated using the nearest neighbour method19. Codons can be fixed or altered to
allow expression improvements. The sequences of the oligonucleotides used in this study
are provided in Supplementary Table 1.
Microchip synthesis, amplification and selection of oligonucleotides
Oligonucleotides were synthesized on photo-programmable microfluidic microchips with
a phosphate at the 5
0
end and the 3
0
end coupling to the 3
0
-hydroxy terminus of a uracil
residue (X. Gao, unpublished work). After synthesis, the oligonucleotides were cleaved
either with RNase A or by ammonium hydroxide treatment (used for deprotection as in
standard oligonucleotide syntheses) followed by precipitation. Gene construction
oligonucleotides that had been PCR amplified with 20-mers (initially complementary to
the terminal ten bases) were digested with the type-IIS restriction enzymes BsaI and BseRI
(without gel purification except for the ‘PAGE’ controls in Table 1). While this paper was
in review a related method using the enzyme MlyI appeared20. Immobilization of biotin-
labelled selection oligonucleotides on magnetic streptavidin beads (Dynal) and removal of
the non-biotinylated strand were done as described21. Construction oligonucleotides were
denatured at 95 8C for 3 min and hybridized to selection oligonucleotides in hybridization
buffer (5 £ SSPET buffer, 50% formamide, 0.2 mg ml21 BSA) for 14–16 h at 42 8C on a
rotor. Beads were washed three times with 0.5 £ SSPET and three times with wash buffer
(20 mM Tris-HCl pH 7.0, 5 mM EDTA, 4 mM NaCl) at room temperature. The
construction oligonucleotides were recovered by denaturation in 0.1 M NaOH for 15 min
and subsequent neutralization.
Polymerase assembly multiplexing reactions
PAM reactions were carried out in 25-ml reactions containing 2 ml of oligonucleotide
mixtures, 0.4 mM of each of the gene-end primer pairs, 1 £ dNTP mixture and 0.5 ml of
Advantage 2 polymerase mixture in 1 £ buffer (Clontech Advantage 2 PCR kit). Samples
were denatured at 95 8C for 3 min, then underwent 40–45 thermal cycles of 95 8C for 30 s,
49 8C for 1 min and 68 8C for 1 min kb21, then finished at 68 8C for 10 min. Sequential
PAM reactions were used to combine multiple genes. First, His6-tagged linear expression
constructs of the correct sequences of 21 ribosomal protein genes were pre-constructed by
PCR using an RTS E. coli linear template generation kit (Roche). These constructs were
then used as templates in separate PCR reactions where unique ,30-mer linkers with
identical Tm (0.4 mM of each, Integrated DNA Technologies, Inc.) were introduced to
create enough overlapping sequences between genes for secondary PAM reactions (see
Supplementary Table 2). In these, three large fragments were made in separate Roche
Expand long template PCR reactions: RS1–5 (1–5,513), RS6–13 (5,483–10,526) and
RS14–21 (10,497–14,593). These fragments were gel-purified and assembled into a full
14,593-bp operon in the final assembly reaction using RS1–21 (1–14,593). For the last two
assemblies, samples were denatured at 92 8C for 2 min, followed by 10 thermal cycles at
92 8C for 30 s, 65 8C for 1 min and 68 8C for 1 min kb21, then followed by 25 additional
cycles at 92 8C for 30 s, 65 8C for 1 min, and 68 8C for 1 min kb21 plus 10 s per cycle, and
finished at 68 8C for 10 min.
Coupled in vitro transcription and translation
Assembled genes were cloned and error-free clones were selected by sequencing. Linear
constructs for in vitro protein expression were made using Roche RTS E. coli linear
template generation set, His-tag. In-vitro-coupled transcription and translation was
performed using a Roche Rapid Translation System RTS 100 E. coli HY kit. Proteins were
detected by western blotting with an anti-His6-peroxidase antibody (Roche) using
standard procedures.
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Ribosomal protein (RP) genes in eukaryotes are coordinately
regulated in response to growth stimuli and environmental
stress, thereby permitting cells to adjust ribosome number and
overall protein synthetic capacity to physiological conditions1–5.
Approximately 50% of RNA polymerase II transcription is
devoted to RP genes5. The transcriptional regulator Rap1 binds
most yeast RP promoters6, and Rap1 sites are important for
coordinate regulation of RP genes7–10. However, Rap1 is not the
specific regulator that controls RP transcription because it also
functions as a repressor, and many Rap1-activated promoters are
not coordinately regulated with RP promoters11,12. Here we show
that the transcription factors Fhl1 and Ifh1 associate almost
exclusively with RP promoters; association depends on Rap1 and
(to a lesser extent) a DNA element at many RP promoters. Ifh1 is
recruited to promoters via the forkhead-associated (FHA)
domain of Fhl1; the level of Ifh1 associated with RP promoters
determines the level of transcription; and environmental stress
causes a marked reduction in the association of Ifh1, but not Fhl1
or Rap1. Thus, Ifh1 association with promoters is the key
regulatory step for coordinate expression of RP genes.
Yeast cells contain ,150 copies of the ribosomal DNA locus and
137 RP genes that encode one or two copies of each of 78 proteins.
Transcription of the RP genes is coordinately regulated in accord
with the cellular growth rate in a manner that requires protein
kinase A and the TOR pathway8,13–15. In addition, RP transcription is
rapidly and coordinately downregulated in response to a variety of
environmental insults such as heat shock, amino-acid starvation
and osmotic shock. Coordinate regulation of RP genes has a major
biological impact on the overall protein synthetic capacity and
growth of the cell, and 50% of RNA polymerase II transcription in
yeast is devoted to RP genes5.
Despite the biological importance of coordinate regulation of RP
genes, information about the mechanism of this regulation is rather
incomplete. Approximately 90% of RP promoters contain predicted
Rap1 binding sites5,16, and Rap1 is bound to essentially all such RP
promoters in vivo6. Rap1 sites are important for growth-regulated
expression of natural RP promoters7–9, and a 41-base-pair (bp)
fragment containing two Rap1 sites from an RP promoter is
sufficient to mediate growth regulation10. However, Rap1 also
binds and activates many non-RP promoters that are not regulated
in the same manner as RP promoters. Furthermore, the Rap1-
dependent activator that regulates transcription of RP genes recruits
TFIID, whereas the Rap1-dependent activator that regulates tran-
scription of glycolytic genes does not10. Taken together, these results
strongly suggest the existence of an unknown protein(s) that is
specifically involved in the coordinate regulation of RP genes.
An extensive genome-wide analysis of target sites for over 100
yeast DNA-binding transcription factors revealed Fhl1, a protein
containing a fork head DNA-binding domain17, as binding specifi-
cally to RP promoters18. We confirmed this result by performing
chromatin immunoprecipitation (ChIP) on Fhl1 coupled with
analysis on microarrays containing essentially all yeast promoter
regions (Fig. 1a; Supplementary Table 1). Using a stringent cutoff of
fivefold enrichment, we identified 79 targets, 76 of which are RP
promoters. At this level of stringency, Fhl1 is almost exclusively
specific to RP promoters. It is highly likely that Fhl1 interacts with
additional RP promoters, as 80% (103 out of 129) of detectable RP
promoter regions are found in the top 5% of the Fhl1-bound targets
(Fig. 1a).
We also determined the genome-wide association of Ifh1, a
protein that interacts genetically with Fhl1 (ref. 19). The binding
profile of Ifh1 is strikingly similar to that of Fhl1, located almost
exclusively at RP promoters (Fig. 1a; Supplementary Table 1). Of the
56 targets showing at least fivefold enrichment, 54 were RP
promoters, and it is likely that Ifh1 associates with additional RP
promoters (Fig. 1a). Remarkably, 94% (51 out of 54) of Ifh1 targets
defined in this manner are also Fhl1 targets. Fhl1 and Ifh1 do not
bind to non-RP, Rap1-containing promoters or to the ribosomal
DNA loci (Fig. 1a, b; data not shown). Ifh1 and Fhl1 do not associate
with eight of the nine RP promoters that do not bind Rap1 in vivo6,16.
Thus, Fhl1 and Ifh1 bind almost exclusively to a common set, but
not all RP promoters, and binding of these proteins seems to be
influenced by Rap1.
Conserved DNA sequence motifs among Fhl1- and Ifh1-bound
promoters include the Rap1 binding site, an A-rich stretch impli-
cated in RP transcription20, and a close match to a sequence
element, ‘Motif 213’, recently identified in a subset of RP promoters
by a computational analysis designed to predict gene expression
using DNA sequence information21 (Fig. 2a; Supplementary Fig. 1).
Analysis of RP promoters that do not display fivefold enrichment of
Fhl1 and Ifh1 identifies the Rap1 site and the A-rich stretch, but not
the third motif. We therefore name the third motif IFHL, and a
search of this motif across the yeast genome shows that it is highly
over-represented at RP gene promoters (P , 0.001). Although the
presence of the IFHL motif correlates with binding of Ifh1 and Fhl1
in vivo, there is not a strict one-to-one correspondence because 38 of
the Fhl1 targets do not contain a clear IFHL motif.
Mapping of Fhl1 and Rap1 binding sites across three RP pro-
moters indicate promoter-specific differences in the relative
locations of these proteins (Fig. 2b–d). At RPL12A, Rap1 and Fhl1
associate with discrete regions, with Rap1 binding near the two
predicted Rap1 sites and Fhl1 binding near the IFHL motif (Fig. 2b).
In contrast, Fhl1 binding at RPS11B and RPL40A matches that of
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